Clinical Trials Browser

Phase 2/3 × Pancreatic Adenocarcinoma × Clear all

NCT05181605 2022-08-09

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Phase 2/3 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

NCT05268692 2022-03-07

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP

Phase 2/3 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma